Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship
Agnieszka Karkucińska‐Więckowska, Inês C. M. Simões, Piotr Kalinowski, et al.
European Journal of Clinical Investigation (2021) Vol. 52, Iss. 3
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

New insights into the role of mitochondrial dynamics in oxidative stress-induced diseases
Sisi Chen, Qilong Li, Hanjing Shi, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117084-117084
Open Access | Times Cited: 33
Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction
Karli R. LeFort, Wiramon Rungratanawanich, Byoung‐Joon Song
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 31
Inequities in primary liver cancer in Europe: The state of play
Loreta A. Kondili, Jeffrey V. Lazarus, Peter Jepsen, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 4, pp. 645-660
Open Access | Times Cited: 19
Exogenous hydrogen sulfide improves non-alcoholic fatty liver disease by inhibiting endoplasmic reticulum stress/NLRP3 inflammasome pathway
Xiaodi Fu, Qi Zhang, Yuhang Chen, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access | Times Cited: 1
Oxidative Stress in Non-Alcoholic Fatty Liver Disease
Carlo Smirne, Eleonora Croce, Davide Di Benedetto, et al.
Livers (2022) Vol. 2, Iss. 1, pp. 30-76
Open Access | Times Cited: 44
Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions
Gao-Xin Xu, Wei Song, Chao Yu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 27
Kaempferol attenuates nonalcoholic fatty liver disease in type 2 diabetic mice via the Sirt1/AMPK signaling pathway
Na Li, Lin Yin, Jiamin Shang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115113-115113
Open Access | Times Cited: 24
Dietary and lifestyle oxidative balance scores are independently and jointly associated with nonalcoholic fatty liver disease: a 20 years nationally representative cross-sectional study
Yuanbin Liu, Mingkai Chen
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 23
Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives
Daniel Clayton‐Chubb, William Kemp, Ammar Majeed, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 687-687
Open Access | Times Cited: 22
Adherence to an antioxidant diet and lifestyle is associated with reduced risk of cardiovascular disease and mortality among adults with nonalcoholic fatty liver disease: evidence from NHANES 1999–2018
Yingzi Li, Yipin Liu
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 10
Altered Mitochondrial Function in MASLD: Key Features and Promising Therapeutic Approaches
Tatjana Radosavljević, Milica Branković, Janko Samardžić, et al.
Antioxidants (2024) Vol. 13, Iss. 8, pp. 906-906
Open Access | Times Cited: 10
Single and combined effects of high-fat diet and ammonia nitrogen on oxidative stress, lipid accumulation and inflammation in liver of grass carp Ctenopharyngodon idella
Cheng Zhang, Wenhao Huang, Xiaotian Zhang, et al.
Aquaculture (2024) Vol. 589, pp. 740973-740973
Closed Access | Times Cited: 8
Oxidative stress in metabolic dysfunction‐associated steatotic liver disease (MASLD): How does the animal model resemble human disease?
Patrycja Jakubek, Piotr Kalinowski, Agnieszka Karkucińska‐Więckowska, et al.
The FASEB Journal (2024) Vol. 38, Iss. 3
Open Access | Times Cited: 7
Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice
Klaus Seedorf, Csaba Weber, Cédric Vinson, et al.
JHEP Reports (2022) Vol. 5, Iss. 4, pp. 100651-100651
Open Access | Times Cited: 29
NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook
Alberto Nascè, Karim Gariani, François R. Jornayvaz, et al.
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1131-1131
Open Access | Times Cited: 28
Mitochondrial Dysfunction in Metabolic Dysfunction Fatty Liver Disease (MAFLD)
Ying Zhao, Yanni Zhou, Dan Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17514-17514
Open Access | Times Cited: 20
Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Soyeon Shin, Jaeyoung Kim, Ju‐Yeun Lee, et al.
Journal of Obesity & Metabolic Syndrome (2023) Vol. 32, Iss. 4, pp. 289-302
Open Access | Times Cited: 19
Mitochondria- and NOX4-dependent antioxidant defense mitigates progression to nonalcoholic steatohepatitis in obesity
Spencer Greatorex, Supreet Kaur, Chrysovalantou E. Xirouchaki, et al.
Journal of Clinical Investigation (2023) Vol. 134, Iss. 3
Open Access | Times Cited: 18
Drug-induced mitochondrial toxicity: Risks of developing glucose handling impairments
Auxiliare Kuretu, Charles Arineitwe, Mamosheledi Mothibe, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16
Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review
Karima Begriche, Clémence Penhoat, Pénélope Bernabeu-Gentey, et al.
Livers (2023) Vol. 3, Iss. 1, pp. 33-53
Open Access | Times Cited: 13
Research progress, challenges and perspectives of phospholipids metabolism in the LXR‑LPCAT3 signaling pathway and its relation to NAFLD (Review)
Junmin Wang, Jiacheng Li, Yugang Fu, et al.
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 4
Open Access | Times Cited: 4
Harnessing Natural Saponins: Advancements in Mitochondrial Dysfunction and Therapeutic Applications
Hongmei Liu, Huan Wang, Xinyu Lin, et al.
Phytomedicine (2025) Vol. 138, pp. 156383-156383
Closed Access
From gut to liver: Exploring the crosstalk between gut-liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease
Mi Zhou, Jianyu Lv, Han Y. H. Chen, et al.
Annals of Hepatology (2025), pp. 101777-101777
Open Access
Research Progress on Rifaximin in Modulating Gut Microbiota for the Treatment of Nonalcoholic Fatty Liver Disease
裕梅 范
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 1218-1225
Closed Access
A network toxicology and molecular docking-based approach revealed shared hepatotoxic mechanisms and targets between the herbicide 2,4-D and its metabolite 2,4-DCP
Rafael Xavier Martins, Cleyton Gomes, Matheus Carvalho, et al.
Toxicology (2025), pp. 154086-154086
Closed Access
Page 1 - Next Page

Scroll to top